I-US Food and Drug Administration igunyaze "uhlelo lokuqala oluhlanganisiwe lokuqapha ushukela wegazi" eShayina ngomhlaka-27 ukuqapha amazinga kashukela egazini ezigulini ezinesifo sikashukela ezingaphezu kweminyaka emibili ubudala, futhi lungasetshenziswa nama-insulin auto-injectors. Kanye neminye imishini esetshenziswa ndawonye.
Lesi siqaphi esibizwa ngokuthi “i-Dkang G6″ siyisiqaphi se-glucose egazini esikhulu kancane kune-dime futhi sibekwe esikhumbeni sesisu ukuze abanesifo sikashukela bakwazi ukukala i-glucose egazini ngaphandle kokufaka inaliti ngomunwe. Isiqaphi singasetshenziswa njalo emahoreni ayi-10. Shintsha kanye ngosuku. Ithuluzi lidlulisela idatha kwisofthiwe yezokwelapha yefoni ephathekayo njalo ngemizuzu emi-5, futhi lixwayisa uma i-glucose yegazi iphezulu kakhulu noma iphansi kakhulu.
Leli thuluzi lingasetshenziswa namanye amadivayisi okuphatha i-insulin njenge-insulin autoinjectors, amaphampu e-insulin, kanye namamitha e-glucose asheshayo. Uma lisetshenziswa kanye ne-insulin auto-injector, ukukhishwa kwe-insulin kubangelwa lapho ushukela wegazi ukhuphuka.
Umuntu ofanele ophethe i-US Drug Administration uthe: “Ingasebenza namadivayisi ahlukene ahambisanayo ukuvumela iziguli ukuthi zakhe amathuluzi okuphatha isifo sikashukela ngokwezifiso.”
Ngenxa yokuhlanganiswa kwayo okungenazihibe neminye imishini, i-US Pharmacopoeia ihlukanise i-Dekang G6 “njengeyesibili” (isigaba esikhethekile sokulawula) kumadivayisi ezokwelapha, okuhlinzeka ngokulula kokuthuthukiswa kwesiqaphi se-glucose esihlanganisiwe esihlanganisiwe esiqhubekayo.
I-US Pharmacopoeia ihlole izifundo ezimbili zezokwelapha. Isampula yayihlanganisa izingane ezingu-324 ezingaphezu kweminyaka engu-2 kanye nabantu abadala abanesifo sikashukela. Akukho miphumela emibi engathi sína etholakele phakathi nesikhathi sokuqapha sezinsuku eziyi-10.
Isikhathi sokuthunyelwe: Julayi-02-2018
